Voya Investment Management LLC Biomarin Pharmaceutical Inc Transaction History

Voya Investment Management LLC

$79.9 Billion
Q3 2024

A detailed history of Voya Investment Management LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Voya Investment Management LLC holds 90,345 shares of BMRN stock, worth $5.73 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

90,345

Previous 89,467 0.98%

Holding current value

$5.73 Million

Previous $7.37 Million 13.78%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $60,599 - $82,391	878 Added 0.98%	90,345 $6.35 Million
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $337,465 - $418,125	4,534 Added 5.34%	89,467 $7.37 Million
Q1 2024 May 15, 2024	SELL	$83.81 - $99.0 $656,148 - $775,071	-7,829 Reduced 8.44%	84,933 $7.42 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $355,337 - $459,253	4,662 Added 5.29%	92,762 $8.94 Million
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $37,600 - $41,760	-442 Reduced 0.5%	88,100 $7.8 Million
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $629,383 - $728,278	7,261 Added 8.93%	88,542 $7.67 Million
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $402,200 - $537,565	4,584 Added 5.98%	81,281 $7.9 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $299,845 - $402,474	3,705 Added 5.08%	76,697 $7.94 Million
Q3 2022 Mar 03, 2023	SELL	$82.16 - $96.94 $304,402 - $359,162	-3,705 Reduced 4.83%	72,992 $6.19 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $4 Million - $4.72 Million	48,645 Added 199.8%	72,992 $6.19 Million
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $88,992 - $108,128	-1,245 Reduced 4.86%	24,347 $2.02 Million
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $241,624 - $308,162	-3,369 Reduced 11.63%	25,592 $2.26 Million
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $9,421 - $10,769	-126 Reduced 0.43%	28,961 $2.24 Million
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $2.08 Million - $2.34 Million	-27,560 Reduced 48.65%	29,087 $2.43 Million
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $43.1 Million - $52.3 Million	-576,153 Reduced 91.05%	56,647 $4.28 Million
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $2.08 Million - $2.59 Million	28,662 Added 4.74%	632,800 $55.5 Million
Q3 2020 Nov 16, 2020	SELL	$71.87 - $131.03 $46.6 Million - $84.9 Million	-647,917 Reduced 51.75%	604,138 $46 Million
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $31.6 Million - $49.3 Million	397,054 Added 46.44%	1,252,055 $154 Million
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $7.16 Million - $9.71 Million	-100,274 Reduced 10.5%	855,001 $72.2 Million
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $10.2 Million - $13.7 Million	159,125 Added 19.99%	955,275 $80.8 Million
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $1.87 Million - $2.36 Million	-27,672 Reduced 3.36%	796,150 $53.7 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $1.57 Million - $1.84 Million	19,570 Added 2.43%	823,822 $70.6 Million
Q1 2019 May 15, 2019	SELL	$84.2 - $98.62 $2.36 Million - $2.77 Million	-28,073 Reduced 3.37%	804,252 $71.4 Million
Q4 2018 Feb 14, 2019	BUY	$80.14 - $106.07 $36.5 Million - $48.3 Million	455,754 Added 121.03%	832,325 $70.9 Million
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $3.43 Million - $3.86 Million	36,494 Added 10.73%	376,571 $36.5 Million
Q2 2018 Aug 14, 2018	SELL	$76.01 - $99.03 $1.2 Million - $1.57 Million	-15,825 Reduced 4.45%	340,077 $32 Million
Q1 2018 May 15, 2018	SELL	$77.67 - $92.63 $31 Million - $37 Million	-399,609 Reduced 52.89%	355,902 $28.9 Million
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $3.3 Million - $3.89 Million	-40,912 Reduced 5.14%	755,511 $67.4 Million
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $64.2 Million - $75.6 Million	796,423	796,423 $74.1 Million

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Biomarin Pharmaceutical Inc Transaction History